We’re now offering DAXXIFY
We’re pleased to introduce DAXXIFY –the only long-lasting, peptide-powered frown line treatment. We’re one of the first exclusive providers to offer this innovative treatment.
DAXXIFY is FDA approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some.*
Conventional injectables last 3 – 4 months and require up to 4 treatments a year to maintain results.
Nearly 90% of patients say they wish results lasted longer. With DAXXIFY, you can keep your frown lines smoother for a full year with as few as 2 treatments.*
Is DAXXIFY well studied?
DAXXIFY was studied in the largest-ever clinical study conducted for a frown line treatment and included more than 2,400 people across different ages and skin types.
- There were no serious treatment-related side effects in clinical trials for DAXXIFY
- The active ingredient in DAXXIFY is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years
- 96% of people treated with DAXXIFY were satisfied with their results †
† 96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies.
Why Are Peptides Important?
All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant.
DAXXIFYTM is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.